Searched over 200M research papers
6 papers analyzed
Some studies suggest low HDL levels are associated with increased risks of death, sepsis, malignancy, and autoimmune diseases, while other studies indicate that the relationship between low HDL and cardiovascular risk can vary by region and population.
20 papers analyzed
Low high-density lipoprotein (HDL) cholesterol is widely recognized as a marker of cardiovascular disease risk. However, this relationship is not straightforward and is often mediated by other risk factors. Studies have shown that low HDL is associated with adverse lifestyle choices, impaired metabolism, and increased cardiovascular risk. Despite this, increasing HDL-C levels has not proven to be a viable therapeutic target, as HDL-C does not necessarily reflect HDL function.
Extremely low levels of HDL (≤20 mg/dL) have been linked to a significantly higher risk of death, sepsis, and malignancy. A study found that patients with very low HDL levels had a 3.98-fold increase in the odds of fever and a 6.7-fold increase in the risk of cancer. Additionally, for each 1 mg/dL increase in HDL, there was an 11% decrease in the odds of sepsis, highlighting the protective role of HDL against infections.
Low HDL-C is also associated with an increased risk of inflammatory disorders. HDL has anti-inflammatory properties, and its low levels can contribute to heightened inflammation, which is a common pathway in various diseases, including cardiovascular diseases and diabetes. The complex molecular regulation of HDL, involving multiple proteins and bioactive lipids, underscores its role in inflammation and immune response.
The prevalence and implications of low HDL can vary significantly across different populations. For instance, in sub-Saharan Africa, low HDL is extremely common and is often associated with lower overall cholesterol levels, which contrasts with the patterns observed in European populations. This suggests that low HDL in isolation may not indicate increased cardiovascular risk in these populations.
There is also evidence linking low HDL levels with a higher risk of autoimmune diseases. A study involving over 117,000 individuals found that those with HDL cholesterol levels below 39 mg/dL had a significantly higher risk of developing autoimmune diseases compared to those with higher HDL levels. This association remained consistent across various subgroups and conditions, indicating a robust link between low HDL and autoimmune risk.
Lifestyle changes, such as weight loss through exercise or dieting, can influence HDL levels. In a study of overweight men, those who engaged in exercise saw increases in HDL levels, with the greatest absolute increases observed in men with normal-to-high baseline HDL levels. This suggests that while lifestyle modifications can improve HDL levels, the extent of improvement may depend on baseline HDL levels.
Low HDL levels are associated with a range of health risks, including cardiovascular diseases, sepsis, malignancy, inflammatory disorders, and autoimmune diseases. The implications of low HDL can vary across different populations and are influenced by various factors, including lifestyle and baseline HDL levels. Understanding these associations is crucial for developing targeted interventions to mitigate the risks associated with low HDL.
Most relevant research papers on this topic